DOI:
10.1055/s-00043364
Pharmaceutical Fronts
LinksClose Window
References
Navari RM.
Safety profile of HTX-019 administered as an intravenous push in cancer patients: a retrospective review.
Expert Opin Drug Saf 2020;
19 (02) 205-210
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.